Wolfgang Serles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wolfgang Serles has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
Christoph Baumgartner
Universitätsklinik für Neurologie, Abteilung für Klinische Epilepsieforschung, Medical University of Vienna, Währinger Gürtel 18-20, A 1090 Vienna, Austria
3 shared publicationsAchim Olbrich
Universitätskliniken für Neurologie, Vienna, Austria
2 shared publications- Anna Cho
Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria
2 shared publications - Arthur Hosmann
Department of Neurosurgery, Medical University of Vienna, 1090 Vienna, Austria
2 shared publications - Brigitte Gatterbauer
Department of Neurosurgery, Medical University of Vienna, Vienna, Austria
2 shared publications - Christian Dorfer
Department of Neurosurgery Medical University of Vienna Vienna Austria
2 shared publications
Latest Publications
- Open Access
Seizure control after radiosurgical treatment in patients with cerebral arteriovenous malformations: An observational study
Objective: Seizures are among the most common symptoms of cerebral arteriovenous malformations (AVMs). Although the main goal of AVM treatment remains complete obliteration, seizure control has become an important treatment aspect in recent years. Thus, we analyzed seizure control following Gamma Knife Radiosurgery (GKRS) treatment at our department in patients with AVMs. Methods: We analyzed 130 patients with AVMs who had at least one seizure before treatment with GKRS at our tertiary referral center between 1992 and 2022. We analyzed predictors for treatment success, including AVM size, Virginia Radiosurgery AVM Scale, Radiosurgery‐Based AVM Score, Spetzler–Ponce class, Spetzler–Martin grade, localization, and identified independent predictors of seizure persistence. Results: Median follow‐up was 9.7 years. Improved seizure control was documented for 89% of patients. Seizure‐free status after radiosurgery was achieved for 78% of patients. Spetzler–Ponce class C (odds ratio [OR] = 4.6) and having multiple seizures before the first GKRS treatment (OR = 3.5) were independent predictors for seizure persistence. Still, 72% of patients with multiple seizures prior to AVM treatment were seizure‐free at last follow‐up. Among patients with multiple seizures, having a high‐grade AVM was identified as an independent predictor of seizure persistence (OR = 12.1). Significance: GKRS, as a stand‐alone management option or in combination with endovascular therapy, is an effective treatment option in AVM management, not only to achieve AVM obliteration but also to control AVM‐related seizures. The Spetzler–Ponce class is a powerful predictor of seizure persistence at last follow‐up, especially in patients with multiple seizures prior to treatment.
Open AccessSeizure control after radiosurgical treatment in patients with cerebral arteriovenous malformations: An observational study
Objective: Seizures are among the most common symptoms of cerebral arteriovenous malformations (AVMs). Although the main goal of AVM treatment remains complete obliteration, seizure control has become an important treatment aspect in recent years. Thus, we analyzed seizure control following Gamma Knife Radiosurgery (GKRS) treatment at our department in patients with AVMs. Methods: We analyzed 130 patients with AVMs who had at least one seizure before treatment with GKRS at our tertiary referral center between 1992 and 2022. We analyzed predictors for treatment success, including AVM size, Virginia Radiosurgery AVM Scale, Radiosurgery‐Based AVM Score, Spetzler–Ponce class, Spetzler–Martin grade, localization, and identified independent predictors of seizure persistence. Results: Median follow‐up was 9.7 years. Improved seizure control was documented for 89% of patients. Seizure‐free status after radiosurgery was achieved for 78% of patients. Spetzler–Ponce class C (odds ratio [OR] = 4.6) and having multiple seizures before the first GKRS treatment (OR = 3.5) were independent predictors for seizure persistence. Still, 72% of patients with multiple seizures prior to AVM treatment were seizure‐free at last follow‐up. Among patients with multiple seizures, having a high‐grade AVM was identified as an independent predictor of seizure persistence (OR = 12.1). Significance: GKRS, as a stand‐alone management option or in combination with endovascular therapy, is an effective treatment option in AVM management, not only to achieve AVM obliteration but also to control AVM‐related seizures. The Spetzler–Ponce class is a powerful predictor of seizure persistence at last follow‐up, especially in patients with multiple seizures prior to treatment.
- Open Access
- 27 June 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (1) , 96-104
Evaluation of Nidus Occlusion After Radiosurgery in Brain Arteriovenous Malformations—A Prospective Study Using Arterial Spin Labeling
BACKGROUND AND OBJECTIVES: The gold standard for the evaluation of brain arteriovenous malformation (AVM) nidus occlusion after stereotactic radiosurgery is digital subtraction angiography (DSA), which is an invasive technique. We evaluated the role of MRI, especially arterial spin labeling (ASL) in the assessment of nidus occlusion after radiosurgery. DSA was used as the gold standard for comparison. METHODS: Fifty radiosurgically treated brain AVMs were included in this prospective single-center study. All patients underwent a standardized MRI protocol including following sequences: 2-dimensional T2w (TSE) in 3 planes, T1-weighted Magnetization Prepared Rapid Gradient Echo (MPRAGE), axial resolve diffusion-weighted imaging, ASL, time of flight, and time-resolved angiography with interleaved stochastic trajectories. Nidus obliteration according to the standardized MRI protocol was evaluated by an experienced neuroradiologist within 3 days after image acquisition and before DSA was subsequently performed as the reference standard. A second observer retrospectively rated MRI images of all 50 cases blinded to clinical and DSA data after the prospective study was concluded. RESULTS: All cases rated as obliterated by the MRI protocol were confirmed by DSA. However, 26 and 28 AVMs were rated as patent by the observers, which was verified in 22 (85/79%) cases by DSA. ASL had the highest sensitivity among all MRI sequences. In 3 patients, ASL was the only sequence that correctly revealed a residual nidus according to 1 observer. Overall, the sensitivity and specificity of the standardized MRI protocol for detection of a residual nidus were 100/100% and 86/79%, respectively. The interobserver agreement was excellent (κ = 0.92, 0.81-1.00). At last follow-up of this prospective study, 70% of AVMs were completely obliterated. CONCLUSION: MRI evaluation of nidus occlusion including ASL is highly sensitive for residual nidus detection and has a high potential to replace invasive DSA examinations for patients who underwent radiosurgery of brain AVMs.
- 27 June 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (1) , 96-104
Open AccessEvaluation of Nidus Occlusion After Radiosurgery in Brain Arteriovenous Malformations—A Prospective Study Using Arterial Spin Labeling
BACKGROUND AND OBJECTIVES: The gold standard for the evaluation of brain arteriovenous malformation (AVM) nidus occlusion after stereotactic radiosurgery is digital subtraction angiography (DSA), which is an invasive technique. We evaluated the role of MRI, especially arterial spin labeling (ASL) in the assessment of nidus occlusion after radiosurgery. DSA was used as the gold standard for comparison. METHODS: Fifty radiosurgically treated brain AVMs were included in this prospective single-center study. All patients underwent a standardized MRI protocol including following sequences: 2-dimensional T2w (TSE) in 3 planes, T1-weighted Magnetization Prepared Rapid Gradient Echo (MPRAGE), axial resolve diffusion-weighted imaging, ASL, time of flight, and time-resolved angiography with interleaved stochastic trajectories. Nidus obliteration according to the standardized MRI protocol was evaluated by an experienced neuroradiologist within 3 days after image acquisition and before DSA was subsequently performed as the reference standard. A second observer retrospectively rated MRI images of all 50 cases blinded to clinical and DSA data after the prospective study was concluded. RESULTS: All cases rated as obliterated by the MRI protocol were confirmed by DSA. However, 26 and 28 AVMs were rated as patent by the observers, which was verified in 22 (85/79%) cases by DSA. ASL had the highest sensitivity among all MRI sequences. In 3 patients, ASL was the only sequence that correctly revealed a residual nidus according to 1 observer. Overall, the sensitivity and specificity of the standardized MRI protocol for detection of a residual nidus were 100/100% and 86/79%, respectively. The interobserver agreement was excellent (κ = 0.92, 0.81-1.00). At last follow-up of this prospective study, 70% of AVMs were completely obliterated. CONCLUSION: MRI evaluation of nidus occlusion including ASL is highly sensitive for residual nidus detection and has a high potential to replace invasive DSA examinations for patients who underwent radiosurgery of brain AVMs.
- Open Access
- 28 September 2021
- Published by Springer Nature in Zeitschrift für Epileptologie
- Vol. 34 (4) , 355-359
Akut symptomatische Anfälle vs. beginnende Epilepsie nach Schlaganfall bei Erwachsenen und Kindern
Zusammenfassung: Mehr als ein Drittel der neu diagnostizierten Epilepsien bei Patienten über 60 Jahren haben einen abgelaufenen Schlaganfall als Ursache. Bei epileptischen Anfällen nach Schlaganfall müssen akut symptomatische Anfälle innerhalb 1 Woche nach Schlaganfall von unprovozierten epileptischen Anfällen ab 1 Woche nach Schlaganfall unterschieden werden. Erstere haben ein niedriges Rezidivrisiko, Zweitere hingegen führen in 70 % zu einem neuerlichen Anfall. Gemäß der Internationalen Liga gegen Epilepsie (ILAE) erfüllt letztere Konstellation bereits die Kriterien einer beginnenden Epilepsie, wofür nach früheren Definitionen zumindest 2 unprovozierte Anfälle notwendig waren. Akut symptomatische Anfälle stellen allerdings sowohl im Kindesalter als auch beim Erwachsenen einen Risikofaktor für die Entwicklung einer Epilepsie dar. Weitere Risikofaktoren sind die Größe des Infarktes und eine Lokalisation im Bereich der Hirnrinde. Die Studienlage zeigt weder ausreichende Evidenz für eine prophylaktische Gabe der Anfallsmedikation nach Schlaganfall noch für eine Therapie nach akut symptomatischem Anfall, obwohl dies häufig klinische Praxis ist. Daher sollte die medikamentöse Therapie nach der Akutphase des Schlaganfalls beendet werden. Bei Schlaganfallpatienten nach einem unprovozierten Anfall beim Erwachsenen wird eine lebenslange Therapie empfohlen. In der Regel stellt sich durch die Gabe eines Medikamentes ein zufriedenstellender Therapieerfolg ein. Bevorzugt werden sollten neuere Anfallsmedikamente, die besser verträglich sind und ein geringeres Interaktionspotenzial im Rahmen der Polypharmazie bei älteren Patienten haben.
- 28 September 2021
- Published by Springer Nature in Zeitschrift für Epileptologie
- Vol. 34 (4) , 355-359
Open AccessAkut symptomatische Anfälle vs. beginnende Epilepsie nach Schlaganfall bei Erwachsenen und Kindern
Zusammenfassung: Mehr als ein Drittel der neu diagnostizierten Epilepsien bei Patienten über 60 Jahren haben einen abgelaufenen Schlaganfall als Ursache. Bei epileptischen Anfällen nach Schlaganfall müssen akut symptomatische Anfälle innerhalb 1 Woche nach Schlaganfall von unprovozierten epileptischen Anfällen ab 1 Woche nach Schlaganfall unterschieden werden. Erstere haben ein niedriges Rezidivrisiko, Zweitere hingegen führen in 70 % zu einem neuerlichen Anfall. Gemäß der Internationalen Liga gegen Epilepsie (ILAE) erfüllt letztere Konstellation bereits die Kriterien einer beginnenden Epilepsie, wofür nach früheren Definitionen zumindest 2 unprovozierte Anfälle notwendig waren. Akut symptomatische Anfälle stellen allerdings sowohl im Kindesalter als auch beim Erwachsenen einen Risikofaktor für die Entwicklung einer Epilepsie dar. Weitere Risikofaktoren sind die Größe des Infarktes und eine Lokalisation im Bereich der Hirnrinde. Die Studienlage zeigt weder ausreichende Evidenz für eine prophylaktische Gabe der Anfallsmedikation nach Schlaganfall noch für eine Therapie nach akut symptomatischem Anfall, obwohl dies häufig klinische Praxis ist. Daher sollte die medikamentöse Therapie nach der Akutphase des Schlaganfalls beendet werden. Bei Schlaganfallpatienten nach einem unprovozierten Anfall beim Erwachsenen wird eine lebenslange Therapie empfohlen. In der Regel stellt sich durch die Gabe eines Medikamentes ein zufriedenstellender Therapieerfolg ein. Bevorzugt werden sollten neuere Anfallsmedikamente, die besser verträglich sind und ein geringeres Interaktionspotenzial im Rahmen der Polypharmazie bei älteren Patienten haben.
- Open Access
- 7 November 2016
- Published by Springer Nature in Journal of Neurology
- Vol. 264 (1) , 131-138
Prehospital and intra-hospital time delays in posterior circulation stroke: results from the Austrian Stroke Unit Registry
Therapeutic effect of recombinant tissue-plasminogen activator (rt-PA) is time dependent. There is limited evidence whether localization of stroke within the posterior circulation (PCS) is associated with a treatment delay. We aimed to analyze within a nationwide multicenter cohort whether duration of pre- and intra-hospital patient management differs between patients with PCS and anterior circulation strokes (ACS). We studied onset-to-door-times (ODT) and door-to-needle-times (DNT) of all patients with acute ischemic stroke (IS) enrolled in the Austrian Stroke Unit Registry according to infarct localization. Classification into PCS and ACS was based on clinical presentation applying the criteria used in the Oxfordshire Community Stroke Project. Relationships between ODT, respectively, DNT and explanatory variables were modeled by multivariate linear regression. Between 2003 and 2015, 71010 patients with IS were enrolled, 11,924 with PCS and 59,086 with ACS. Overall, the ODT was significantly longer in PCS: median (IQR): 170 (25th, 75th‰: 79,420) min versus 110 (60,240); p < 0.001; this finding held true in multivariable analysis. In 10535 rt-PA-treated patients (1022 PCS/9832 ACS), ODT and DNT were significantly longer among those with PCS: ODT: median: 80 min (55,120) versus 72 (50,110), p < 0.001; DNT: 57 (35.90) versus 45 (30.67), p < 0.001. In the multivariate model, PCS was significantly associated with delay in the DNT. In conclusion, in this large nationwide cohort, patient management was significantly slower in PCS as compared to ACS. Increasing awareness about these delays and further elaboration of the underlying causes may translate into higher proportions of patients with PCS receiving rt-PA.
- 7 November 2016
- Published by Springer Nature in Journal of Neurology
- Vol. 264 (1) , 131-138
Open AccessPrehospital and intra-hospital time delays in posterior circulation stroke: results from the Austrian Stroke Unit Registry
Therapeutic effect of recombinant tissue-plasminogen activator (rt-PA) is time dependent. There is limited evidence whether localization of stroke within the posterior circulation (PCS) is associated with a treatment delay. We aimed to analyze within a nationwide multicenter cohort whether duration of pre- and intra-hospital patient management differs between patients with PCS and anterior circulation strokes (ACS). We studied onset-to-door-times (ODT) and door-to-needle-times (DNT) of all patients with acute ischemic stroke (IS) enrolled in the Austrian Stroke Unit Registry according to infarct localization. Classification into PCS and ACS was based on clinical presentation applying the criteria used in the Oxfordshire Community Stroke Project. Relationships between ODT, respectively, DNT and explanatory variables were modeled by multivariate linear regression. Between 2003 and 2015, 71010 patients with IS were enrolled, 11,924 with PCS and 59,086 with ACS. Overall, the ODT was significantly longer in PCS: median (IQR): 170 (25th, 75th‰: 79,420) min versus 110 (60,240); p < 0.001; this finding held true in multivariable analysis. In 10535 rt-PA-treated patients (1022 PCS/9832 ACS), ODT and DNT were significantly longer among those with PCS: ODT: median: 80 min (55,120) versus 72 (50,110), p < 0.001; DNT: 57 (35.90) versus 45 (30.67), p < 0.001. In the multivariate model, PCS was significantly associated with delay in the DNT. In conclusion, in this large nationwide cohort, patient management was significantly slower in PCS as compared to ACS. Increasing awareness about these delays and further elaboration of the underlying causes may translate into higher proportions of patients with PCS receiving rt-PA.
- 3 February 2016
- Published by Wiley in European Journal of Neurology
- Vol. 23 (5) , 906-911
Endovascular stroke therapy in Austria: a nationwide 1‐year experience
Background and purpose: Based on a tight network of stroke units (SUs) and interventional centres, endovascular treatment of acute major intracranial vessel occlusion has been widely implemented in Austria. Documentation of all patients in the nationwide SU registry has thereby become mandatory.Methods: Demographic, clinical and interventional characteristics of patients who underwent endovascular treatment for acute ischaemic stroke in 11 Austrian interventional centres between 1 October 2013 and 30 September 2014 were analysed.Results: In total, 301 patients (50.5% women; median age 70.5 years; median National Institutes of Health Stroke Scale score 17) were identified.193 patients (64.1%) additionally received intravenous thrombolysis. The most frequent vessel occlusion sites were the M1 segment of the middle cerebral artery (n = 161, 53.5%), the intracranial internal carotid artery (n = 60, 19.9%) and the basilar artery (n = 40, 13.3%). Stent retrievers were used in 235 patients (78.1%) and adequate reperfusion (modified Thrombolysis in Cerebral Infarction scores 2b and 3, median onset to reperfusion time 254 min) was achieved in 242 patients (81.4%). Symptomatic intracranial haemorrhage occurred in 7%. 43.8% of patients (n = 132) had good functional outcome (modified Rankin Scale score 0–2) and the mortality rate was 20.9% (n = 63) after 3 months. Compared to the anterior circulation, vertebrobasilar stroke patients had higher mortality. Patients with secondary hospital transportation had better outcomes after 3 months than in‐house treated patients.Conclusion: Our results document nationwide favourable outcome and safety rates of endovascular stroke treatment comparable to recent randomized trials. The ability to provide such data and the need to further optimize such an approach also underscore the contribution of respective registries.
- 3 February 2016
- Published by Wiley in European Journal of Neurology
- Vol. 23 (5) , 906-911
Endovascular stroke therapy in Austria: a nationwide 1‐year experience
Background and purpose: Based on a tight network of stroke units (SUs) and interventional centres, endovascular treatment of acute major intracranial vessel occlusion has been widely implemented in Austria. Documentation of all patients in the nationwide SU registry has thereby become mandatory.Methods: Demographic, clinical and interventional characteristics of patients who underwent endovascular treatment for acute ischaemic stroke in 11 Austrian interventional centres between 1 October 2013 and 30 September 2014 were analysed.Results: In total, 301 patients (50.5% women; median age 70.5 years; median National Institutes of Health Stroke Scale score 17) were identified.193 patients (64.1%) additionally received intravenous thrombolysis. The most frequent vessel occlusion sites were the M1 segment of the middle cerebral artery (n = 161, 53.5%), the intracranial internal carotid artery (n = 60, 19.9%) and the basilar artery (n = 40, 13.3%). Stent retrievers were used in 235 patients (78.1%) and adequate reperfusion (modified Thrombolysis in Cerebral Infarction scores 2b and 3, median onset to reperfusion time 254 min) was achieved in 242 patients (81.4%). Symptomatic intracranial haemorrhage occurred in 7%. 43.8% of patients (n = 132) had good functional outcome (modified Rankin Scale score 0–2) and the mortality rate was 20.9% (n = 63) after 3 months. Compared to the anterior circulation, vertebrobasilar stroke patients had higher mortality. Patients with secondary hospital transportation had better outcomes after 3 months than in‐house treated patients.Conclusion: Our results document nationwide favourable outcome and safety rates of endovascular stroke treatment comparable to recent randomized trials. The ability to provide such data and the need to further optimize such an approach also underscore the contribution of respective registries.
- 7 November 2007
- Published by Elsevier in Brain Research
- Vol. 1179, 131-139
Decrease of NAA with aging outside the seizure focus in mesial temporal lobe epilepsy—A proton-MRS study at 3 Tesla
- 7 November 2007
- Published by Elsevier in Brain Research
- Vol. 1179, 131-139
Decrease of NAA with aging outside the seizure focus in mesial temporal lobe epilepsy—A proton-MRS study at 3 Tesla
- 6 March 2006
- Published by Wiley in NMR in Biomedicine
- Vol. 19 (5) , 544-553
1H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy
The objectives of this work were to compare concentrations of N‐acetylaspartate (NAA), glutamate (Glu), glutamine (Gln), Glx (=Glu + Gln), myo‐inositol (mI), total creatine (Cre) and other metabolites in the temporal lobes of patients with mesial temporal lobe epilepsy (mTLE), cryptogenic TLE (cTLE), who show no abnormalities in high‐resolution MRI, and healthy controls using single voxel 1H MRS at 3 T. Twelve patients with mTLE, nine with cTLE and 22 controls were investigated using a short echo time STEAM protocol. Voxels were positioned bilaterally in the medial and lateral temporal lobes. Spectra were processed with LCModel. Significantly lower mean NAA were detected in mTLE patients (P < 0.001) and a trend towards lower NAA in cTLE patients compared to controls (P = 0.053). Glx was not different between groups. Estimates of Glu showed a different metabolic pattern in mTLE with elevated Glu in lateral compared with medial voxels on the ipsilateral side to seizure onset (P = 0.019). MI concentrations were significantly lower in cTLE (P < 0.001) and in mTLE patients (P = 0.005) compared with healthy controls. MI/Cre was significantly reduced in cTLE patients only (P = 0.004). The results confirm low NAA in mTLE and to a lesser extent in cTLE patients. MI and mI/Cre were identified as potential metabolic indicators of the epileptogenic area in cTLE. Copyright © 2006 John Wiley & Sons, Ltd.
- 6 March 2006
- Published by Wiley in NMR in Biomedicine
- Vol. 19 (5) , 544-553
1H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy
The objectives of this work were to compare concentrations of N‐acetylaspartate (NAA), glutamate (Glu), glutamine (Gln), Glx (=Glu + Gln), myo‐inositol (mI), total creatine (Cre) and other metabolites in the temporal lobes of patients with mesial temporal lobe epilepsy (mTLE), cryptogenic TLE (cTLE), who show no abnormalities in high‐resolution MRI, and healthy controls using single voxel 1H MRS at 3 T. Twelve patients with mTLE, nine with cTLE and 22 controls were investigated using a short echo time STEAM protocol. Voxels were positioned bilaterally in the medial and lateral temporal lobes. Spectra were processed with LCModel. Significantly lower mean NAA were detected in mTLE patients (P < 0.001) and a trend towards lower NAA in cTLE patients compared to controls (P = 0.053). Glx was not different between groups. Estimates of Glu showed a different metabolic pattern in mTLE with elevated Glu in lateral compared with medial voxels on the ipsilateral side to seizure onset (P = 0.019). MI concentrations were significantly lower in cTLE (P < 0.001) and in mTLE patients (P = 0.005) compared with healthy controls. MI/Cre was significantly reduced in cTLE patients only (P = 0.004). The results confirm low NAA in mTLE and to a lesser extent in cTLE patients. MI and mI/Cre were identified as potential metabolic indicators of the epileptogenic area in cTLE. Copyright © 2006 John Wiley & Sons, Ltd.
- Open Access
A Case of Startle Epilepsy and SSMA Seizures Documented with Subdural Recordings
Summary: Purpose: To study the mechanisms of startle‐induced supplementary sensorimotor area (SSMA) seizures. Methods: We present a patient investigated with indwelling subdural grid electrodes covering both the SSMA and the dorsolateral frontal lobe. Results: We found a simultaneous seizure onset in the right dorsolateral premotor cortex and the right SSMA. High‐resolution magnetic resonance imaging (MRI) showed a small subcortical lesion adjacent to the right SSMA. The patient became seizure free after resection of the lesion and the ictalonset zone. Conclusions: We conclude that an extended region of abnormally excitable tissue within the frontal lobe could facilitate the generation of startle‐induced seizures. We speculate that a widespread epileptogenic zone could help to explain why some patients with SSMA or dorsolateral frontal lobe seizures are more likely to have startle‐induced seizures.
Open AccessA Case of Startle Epilepsy and SSMA Seizures Documented with Subdural Recordings
Summary: Purpose: To study the mechanisms of startle‐induced supplementary sensorimotor area (SSMA) seizures. Methods: We present a patient investigated with indwelling subdural grid electrodes covering both the SSMA and the dorsolateral frontal lobe. Results: We found a simultaneous seizure onset in the right dorsolateral premotor cortex and the right SSMA. High‐resolution magnetic resonance imaging (MRI) showed a small subcortical lesion adjacent to the right SSMA. The patient became seizure free after resection of the lesion and the ictalonset zone. Conclusions: We conclude that an extended region of abnormally excitable tissue within the frontal lobe could facilitate the generation of startle‐induced seizures. We speculate that a widespread epileptogenic zone could help to explain why some patients with SSMA or dorsolateral frontal lobe seizures are more likely to have startle‐induced seizures.